‘Natural’ isn’t the same thing as healthful. You can have too much of a good thing, and taking action can be worse than doing nothing.
Academic rigor, journalistic flair
Articles on Drug regulation
Displaying all articles
An inhaler that costs nearly $300 in the US goes for just $9 in Germany. What gives?
Psychedelics are an opportunity to do better than our past drug control strategies. Adults should be trusted to make the right decisions, but policymakers should ensure they do so fully informed.
As the government’s oldest consumer protection agency, the FDA has long butted up against drugmakers, activists and politicians. But undermining its work could be harmful to patient health and safety.
India’s drug regulation is loose and results in dangerous medicines being sold at home and abroad.
Kava is not commonly used in Australia. But that will change and we need to keep an eye on what happens next.
Livelihoods which communities have relied on for centuries are being criminalised by heavy-handed state restrictions.
Australia is still aiming to start vaccinating high-risk groups from March. Why the delay?
Health Canada devotes far more resources to getting new drugs onto the market compared to making sure that drugs already being sold are safe.
Opioid-related deaths in Australia have been on an upward trend in recent years, having doubled since 2006.
From 2021, Australians will no longer be able to buy nicotine-containing e-fluids, without both a prescription and someone licensed to import it for them, raising fears many will go back to smoking.
Intuitively, it might seem desirable to speed up access to medicines. But this means more drugs will be approved that may subsequently prove unsafe or ineffective.
Why are animals still being used in drug development and what are the alternatives that could end their use altogether?
The thalidomide tragedy changed how medicines are viewed during pregnancy – not only by pregnant women, but also the wider community.
Tighter regulations of medicines and devices have prevented countless deaths and disabilities. But regulation can’t always protect us from harm.
Thalidomide caused thousands of spontaneous abortions and left more than 10,000 children severely disabled. What guarantee is there that the same thing can’t occur again today?
Combination drugs are considered an innovation of India’s medicines industry but they are not as safe as they should be.
Imagine being pregnant while having a chronic health condition such as diabetes, hypertension, depression or asthma, or being diagnosed with an illness while pregnant. Amazingly, your doctor may not know…
Between 2005 and 2011, nearly half of all new drug formulations in the US were approved without companies having to demonstrate a tangible benefit, such as relieving disease symptoms, extending life, or…
China is in the midst of conducting a series of corruption investigations of pharmaceutical companies that have been operating in the country. It all started with the investigation of officials from pharmaceutical…
Top contributors
-
Professor of Bioethics, Macquarie University
-
Joel Lexchin is a Friend of The Conversation.
Professor Emeritus of Health Policy and Management, York University, Canada
-
Reader in Clinical Pharmacology and Medical Education, Queen Mary University of London
-
Professor of Law and Public Health, The Ohio State University
-
Professor of Public Health, Newcastle University
-
Assistant Director of Pharmacy, Mater Health SEQ in conjoint appointment as Associate Professor of Pharmacology, Bond University and as Associate Professor (Clinical), The University of Queensland
-
Professor in Psychiatry and Behavioral Sciences and Obstetrics and Gynecology, Northwestern University
-
Professor of Obstetrics and Gynecology, Thomas Jefferson University
-
Head of Alcohol and other Drug Research, Centre for Population Health; Burnet Principal for Alcohol, other drugs and harm reduction, Burnet Institute
-
Macquarie University Research Fellow, Macquarie University
-
Honorary Lecturer, School of Pharmacy, Charles Perkins Centre, University of Sydney
-
Associate Professor of History, University of Wollongong
-
Associate professor, School of Pharmacy and Charles Perkins Centre, University of Sydney
-
Principal Enterprise Fellow, University of Huddersfield
-
NHMRC Senior Research Fellow, Burnet Institute
